Expert Rev Endocrinol Metab. 2010;5(3):331-342. Metformin also forms the cornerstone of dual therapy and is used extensively in combination with several classes of OADs. The safety and efficacy of SU ...
Summarized are OATP1B1 drug substrates showing an increase in maximal plasma concentration (C max) and AUC due to interaction with the respective inhibitor (gemfibrozil, ciclosporin or rifampin).
PrandiMet stimulates release of insulin, improves insulin sensitivity, and decreases gluconeogenesis PrandiMet stimulates the release of insulin, improves insulin sensitivity, and decreases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results